Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

CAD clinical trials

2 of 5 indexed CAD trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

CAD: 5 US clinical trials tracked, 2 recruiting.

CAD is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is CardioDx, running 2 of these trials.

Enrollment posture brief

Registry condition cad

OPEN 2 | RECR 40% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%CAD (this)40%
Open-enrollment share among volume-matched conditions near CAD

CAD lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for CAD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. CAD is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates CAD research.

    CardioDx accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical CAD enrolment sits around 581 participants.

    Median target enrolment is 581 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. CAD research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

CardioDx 2 trials
Abbott Medical Devices 1 trials
National Heart, Lung, and Blood Institute (NHLBI) 1 trials
Stanford University 1 trials

Named interventions

Most-linked intervention names on CAD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Corus CAD (ASGES) Diagnostic test
2 trials
Diamondback 360® Coronary OAS Micro Crown Device
1 trials
MRI scans - obj 4 Device
1 trials
MRI scans - obj 3 Device
1 trials
MRI scans - obj 2 Device
1 trials
MRI scan - obj 1 Device
1 trials

US sites by state

Facility locations filed on CAD trials. A trial with sites in several states counts in each.

California 3 trials
Pennsylvania 2 trials
North Carolina 2 trials
Virginia 1 trials
Utah 1 trials
Tennessee 1 trials
New York 1 trials
Mississippi 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this CAD page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This CAD condition card totals 5 registered trials; most-linked intervention Corus CAD (ASGES); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.